RadNet Raises 2026 Guidance Amid Strong Performance

RadNet Raises 2026 Guidance Amid Strong Performance
RadNet announced significant growth momentum during its Q1 2026 earnings call, signaling annual recurring revenue exceeding $140 million while raising full-year imaging center guidance by $30 million. The company reported record quarterly revenue and EBITDA figures, demonstrating operational excellence across its diversified portfolio. PET/CT imaging services showed particularly robust growth, reflecting strong demand in oncology and cardiology diagnostics. The DeepHealth artificial intelligence platform experienced a notable surge in annual recurring revenue, validating RadNet's strategic shift toward value-added diagnostic services and technology integration. These results underscore management's confidence in sustained market demand for advanced imaging solutions and the successful monetization of its technology investments.